If there’s any doubt that the Baby Boomers are driving medical innovation, then this Israeli-born “personal cellular-digital” ECG should put that question to rest once and for all.
The CardioSen’C is a personal cellular-digital 12 lead ECG transmitter which transmits to SHL’s medical call centre a patient’s 12 lead ECG for the purpose of remote real time diagnosis of arrhythmia, ischemia, and myocardial infarction. The ECG is then analysed by the medical professionals at SHL’s medical call centre and together with a clinical description given by the patient provide the medical professionals with the data needed to diagnose the situation and provide medical assistance, if necessary. This telemedicine service can help to drastically reduce morbidity and mortality rates following an acute myocardial infarction or other severe cardiac incidents.
Simultaneous real time 12 lead ECG sampling (only 3 seconds) for improved quality and faster rate of transmission. Transmission of digital encoded ECG data through a built-in cellular modem allows for maximal ECG accuracy due to the elimination of background noises present when using acoustic transmission via regular telephone lines. In case of no cellular reception the device transmits the ECG acoustically. Enables the medical professionals at the medical call centre to remotely operate and control the device. This promises a calm, clear and effortless transmission on the part of the user. Innovative design with advanced ergonomics which includes an LCD display and vocal guidance. New electrodes design for enhanced contact and conductivity.